Dublin, May 14, 2019 (GLOBE NEWSWIRE) -- The "Global Nuclear Imaging Equipment Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
The nuclear imaging equipment market will register a CAGR of over 6% by 2023.
Increasing number of patients with cancer and cardiac ailments will drive the global market during the forecast period. The increasing number of patients imply the conduction of more tests for diagnosis and treatment. The increased use of nuclear imaging systems will accelerate the growth of the global nuclear imaging equipment market.
Market Overview
Advances in radiotracers
Existing radiotracers and the development of new radiotracers represent both advances in technology and clinical trends. Therefore, advances of radiotracers and their applications in scans will augment the growth of the global nuclear imaging equipment market during the forecast period.
High cost of nuclear imaging equipments and technologies
Single photon emission computed tomography (SPECT) and positron emission tomography (PET) scanning are two types of nuclear imaging systems. PET requires a large amount of cyclotron, which is expensive for producing most of the isotopes. Therefore, such systems are concentrated on a handful of well-funded and specialized healthcare institutions.
Competitive Landscape
The market appears to be highly fragmented and with the presence of several companies including Neusoft Corp. and Siemens Healthcare GmbHthe, competitive environment is quite intense. Factors such as the advances in radiotracers and increasing number of patients with cancer and cardiac ailments, will provide considerable growth opportunities to nuclear imaging equipment manufactures.
Canon Inc., GE Healthcare Inc., Koninklijke Philips NV, Mediso Ltd., Neusoft Corp., and Siemens Healthcare GmbH. are some of the major companies covered in this report.
Key Topics Covered:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis
PART 04: MARKET SIZING
Market definition
Market sizing 2018
Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
Market segmentation by product
Comparison by product
SPECT systems - Market size and forecast 2018-2023
Hybrid PET systems - Market size and forecast 2018-2023
Planar scintigraphy - Market size and forecast 2018-2023
Market opportunity by product
PART 07: MARKET SEGMENTATION BY APPLICATION
Market segmentation by application
Comparison by application
Cardiology - Market size and forecast 2018-2023
Oncology - Market size and forecast 2018-2023
Neurology - Market size and forecast 2018-2023
Others - Market size and forecast 2018-2023
Market opportunity by application
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2018-2023
Europe - Market size and forecast 2018-2023
Asia - Market size and forecast 2018-2023
ROW - Market size and forecast 2018-2023
Key leading countries
Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 12: MARKET TRENDS
Constant discovery and developments of new radiopharmaceuticals
Development in diagnostic imaging
Emerging economies
PART 13: VENDOR LANDSCAPE
Overview
Landscape disruption
PART 14: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
Canon Inc.
GE Healthcare Inc.
Koninklijke Philips NV
Mediso Ltd.
Neusoft Corp.
Siemens Healthcare GmbH
For more information about this report visit https://www.researchandmarkets.com/r/k6mmqw
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.